CN Patent
CN114149437A — 一种吡咯并嘧啶五元氮杂环衍生物及其制备方法和用途
Assigned to Anhui University · Expires 2022-03-08 · 4y expired
What this patent protects
本发明涉及一种吡咯并嘧啶五元氮杂环衍生物及其制备方法和用途,所述的吡咯并嘧啶五元氮杂环衍生物合成方法简单高效,可用于包括炎性疾病、自身免疫疾病以及癌症相关疾病的治疗。
USPTO Abstract
本发明涉及一种吡咯并嘧啶五元氮杂环衍生物及其制备方法和用途,所述的吡咯并嘧啶五元氮杂环衍生物合成方法简单高效,可用于包括炎性疾病、自身免疫疾病以及癌症相关疾病的治疗。
Drugs covered by this patent
- Olumiant (baricitinib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.